CAJ | 학술논문

目的：分析自发性蛛网膜下腔出血(spontaneous subarachnoid hemorrhage，sSAH)患者发生脑积水的危险因素，并探讨其临床特点、治疗方法及疗效。方法：选取南通大学附属医院神经外科2003年1月-2013年12月间收治的的356例sSAH患者，对其中51例sSAH并发脑积水患者的临床资料进行回顾性分析。结果：影响sSAH并发脑积水的高危因素主要有Hurt-Hess分级、Fish分级、动脉瘤部位、反复多次出血等。51例患者分别实施脑室外引流术、V-P分流术后，经GOS评分：良好25例，轻度残疾16例，中度残疾7例，重度残疾3例。结论：在临床治疗中根据患者病情早期选取介入栓塞或者开颅手术治疗方案并配合使用相对应的引流术，可降低术后患者的致残率，提高临床治疗效果。
목적：분석자발성주망막하강출혈(spontaneous subarachnoid hemorrhage，sSAH)환자발생뇌적수적위험인소，병탐토기림상특점、치료방법급료효。방법：선취남통대학부속의원신경외과2003년1월-2013년12월간수치적적356례sSAH환자，대기중51례sSAH병발뇌적수환자적림상자료진행회고성분석。결과：영향sSAH병발뇌적수적고위인소주요유Hurt-Hess분급、Fish분급、동맥류부위、반복다차출혈등。51례환자분별실시뇌실외인류술、V-P분류술후，경GOS평분：량호25례，경도잔질16례，중도잔질7례，중도잔질3례。결론：재림상치료중근거환자병정조기선취개입전새혹자개로수술치료방안병배합사용상대응적인류술，가강저술후환자적치잔솔，제고림상치료효과。
Objective:To analyze spontaneous subarachnoid hemorrhage ( sSAH ) risk factors of hydrocephalus in patients with, and to explore its clinical characteristics, treatment methods and curative effect of progress. Methods: 356 sSAH pa-tients were randomly selected from our hospital neurosurgery in January 2003 to December 2013,including 51 concurrent hy-drocephalus patients,whose clinical diagnosis and treatment data were analyzed retrospectively. Results: Trigger sSAH con-current main risk factors of hydrocephalus: Hunt-Hess classification, Fish classification and aneurysm location, repeated hemorrhage and so on. 51 patients were treated with the implementation of ventricle drainage or V-P bypass surgery , whose GCS score showed that 25 cases recovered well, 16 cases were mild invalid, 7 cases were moderate disabled, severely dis-abled for 3 cases. Conclusions: Long-term clinical studies had confirmed that the sSAH concurrent hydrocephalus disease prevention first need to start from the early onset of treatment, and during the whole therapy performed preventive treatment theory. According to the patients in the clinical treatment of selected interventional embolization or surgical operation treat-ment and drainage, together with the corresponding in order to reduce the morbidity of postoperative patients and to improve the clinical therapeutic effect.